← All stocks

Johnson & Johnson

JNJ Net selling
CIK 0000200406 #269 in the set updated 17 Sep 2026
Bought (120 mo)
$2.20M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$476.65M
$0.00 on a plan · $390.22M straight out of an exercise
Sold at will
$86.43M
246 of 409 sales
Net
−$474.46M
−$84.24M against sales at will

By person

32 insiders · 434 transactions
52.6×

J. Duato holds 52.6 times base salary in stock. $84.30M of shares against $1.60M in salary for 2025.

Salary from the company's own proxy. The shares are what J. Duato last reported holding, valued at $274.74, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Duato Joaquin
CEO and Chairman of the Board
$101.34M (9) scheduled
−$101.34M
306,819
0.0127%
$84.30M
+539.7%
Fasolo Peter
Exec VP, Chief HR Officer
$52.78M (280)
−$52.78M
112,076
0.0047%
$30.79M
+127.5%
Gorsky Alex
Director
$38.60M (1) scheduled
−$38.60M
766,584
0.0318%
$210.61M
+333.1%
Taubert Jennifer L
EVP, WWC. Innovative Medicine
$36.87M (4) scheduled
−$36.87M
194,451
0.0081%
$53.42M
+198.9%
Stoffels Paulus
Vice Chair, Exec Committee
$36.43M (3) scheduled
−$36.43M
275,547
0.0114%
$75.70M
+124.5%
Wolk Joseph J
Exec VP, CFO
$29.40M (8) scheduled
−$29.40M
82,835
0.0034%
$22.76M
+714.7%
Sneed Michael E
EVP, Global Corp Aff & CCO
$25.36M (4) scheduled
−$25.36M
62,177
0.0026%
$17.08M
+55.9%
REED JOHN C
EVP, Innovative Medicine, R&D
$20.42M (5) scheduled
−$20.42M
24,911
0.0010%
$6.84M
+653.5%
Mongon Thibaut
Exec VP, WW Chair, Cons Health
$17.93M (40) scheduled
−$17.93M
65,915
0.0027%
$18.11M
+23.1%
McEvoy Ashley
EVP, WW Chair, MedTech
$17.14M (3) scheduled
−$17.14M
54,253
0.0023%
$14.91M
+355.1%
Wengel Kathryn E
EVP, Chief TO and Risk Officer
$16.93M (10) scheduled
−$16.93M
114,288
0.0047%
$31.40M
+169.0%
Swanson James D.
EVP, CIO
$15.27M (4) scheduled
−$15.27M
25,698
0.0011%
$7.06M
+2,205%
Schmid Timothy
EVP, WW Chair, MedTech
$15.15M (6) scheduled
−$15.15M
26,251
0.0011%
$7.21M
+168.3%
Caruso Dominic J
Exec VP, Finance; CFO
$11.29M (1) scheduled
−$11.29M
171,659
0.0071%
$47.16M
+47.1%
Hait William
EVP, Chief EI and Med Officer
$10.55M (11) scheduled
−$10.55M
38,647
0.0016%
$10.62M
+141.6%
Decker Robert J
VP Corporate Controller
$9.28M (9) scheduled
−$9.28M
23,682
0.0010%
$6.51M
+90.3%
Broadhurst Vanessa
EVP, Global Corp Affairs
$8.74M (3) scheduled
−$8.74M
23,003
0.0010%
$6.32M
+84.2%
Kapusta Ronald A
Controller, CAO
$4.62M (4)
−$4.62M
17,757
0.0007%
$4.88M
−31.0%
Forminard Elizabeth
EVP, Chief Legal Officer
$4.09M (2) scheduled
−$4.09M
16,994
0.0007%
$4.67M
+429.2%
Ullmann Michael H
Exec VP, General Counsel
$2.45M (1) scheduled
−$2.45M
158,835
0.0066%
$43.64M
+73.7%
Pruden Gary J
Exec VP, WW Chair, Med Devices
$1.99M (1)
−$1.99M
43,630
0.0018%
$11.99M
0.0%
Joly Hubert
Director
$706.40K (1)
+$706.40K
5,000
0.0002%
$1.37M
HEWSON MARILLYN A
Director
$419.04K (1)
+$419.04K
3,000
0.0001%
$824.22K
PRINCE CHARLES
Director
$368.58K (2)
+$368.58K
28,520
0.0012%
$7.84M
+11.2%
MORIKIS JOHN G
Director
$257.69K (1)
+$257.69K
1,849
<0.0001%
$507.86K
+208.9%
PEREZ WILLIAM D
Director
$197.75K (2)
+$197.75K
25,130
0.0010%
$6.90M
−12.5%
WEINBERGER MARK A
Director
$147.22K (1)
+$147.22K
1,000
<0.0001%
$274.74K
MULCAHY ANNE M
Director
$100.05K (1)
+$100.05K
6,537
0.0003%
$1.80M
+12.9%
PETERSON SANDRA E
Exec VP, Group WW Chairman
83,349
0.0035%
$22.90M
+133.8%
Mammen Mathai
EVP, Pharm, R&D
41,934
0.0017%
$11.52M
+29.1%
Mesquita Jorge S.
Exec VP, WW Chair, Consumer
27,344
0.0011%
$7.51M
Mulholland Kristen
EVP, Chief HR Officer
19,830
0.0008%
$5.45M
+69.6%
Insider
Date
Role
Action
Shares
Price
Amount
Schmid Timothy
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
22,527
$274.74
$6.19M
Schmid Timothy
2 Sep 2026
EVP, WW Chair, MedTech
Sold after exercise
11,070
$274.74
$3.04M
Taubert Jennifer L
17 Aug 2026
EVP, WWC. Innovative Medicine
Sold after exercise
15,000
$263.36
$3.95M
Duato Joaquin
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
102,315
$261.00
$26.70M
Duato Joaquin
13 Aug 2026
CEO and Chairman of the Board
Sold after exercise
20,976
$262.00
$5.50M
Forminard Elizabeth
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
6,574
$255.93
$1.68M
Forminard Elizabeth
6 Aug 2026
EVP, Chief Legal Officer
Sold after exercise
9,344
$257.76
$2.41M
Broadhurst Vanessa
20 Jul 2026
EVP, Global Corp Affairs
Sold after exercise
23,054
$251.27
$5.79M
Wengel Kathryn E
11 Jun 2026
EVP, Chief TO and Risk Officer
Sold after exercise
10,000
$241.15
$2.41M
Decker Robert J
27 Feb 2026
VP Corporate Controller
Sold after exercise
4,075
$247.87
$1.01M
Schmid Timothy
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
8,998
$244.53
$2.20M
Schmid Timothy
18 Feb 2026
EVP, WW Chair, MedTech
Sold after exercise
13,625
$244.20
$3.33M
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
2,283
$243.00
$554.77K
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
29,927
$243.00
$7.27M
REED JOHN C
17 Feb 2026
EVP, Innovative Medicine, R&D
Sold after exercise
21,721
$243.00
$5.28M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
24,961
$242.68
$6.06M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
33,386
$242.75
$8.10M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
12,066
$242.87
$2.93M
Wolk Joseph J
17 Feb 2026
Exec VP, CFO
Sold after exercise
19,241
$242.99
$4.68M
Swanson James D.
17 Feb 2026
EVP, CIO
Sold after exercise
20,521
$242.70
$4.98M
Swanson James D.
13 Feb 2026
EVP, CIO
Sold after exercise
22,191
$243.71
$5.41M
Swanson James D.
13 Feb 2026
EVP, CIO
Sold after exercise
19,368
$243.76
$4.72M
REED JOHN C
17 Oct 2025
EVP, Innovative Medicine, R&D
Sold after exercise
21,721
$192.71
$4.19M
Taubert Jennifer L
4 Sep 2025
EVP, WWC. Innovative Medicine
Sold after exercise
56,471
$177.81
$10.04M
Duato Joaquin
22 Aug 2025
CEO and Chairman of the Board
Sold after exercise
125,824
$179.21
$22.55M
Wolk Joseph J
15 Aug 2025
Exec VP, CFO
Sold after exercise
16,820
$176.91
$2.98M
Decker Robert J
25 Feb 2025
VP Corporate Controller
Sold after exercise
6,999
$165.88
$1.16M
Wolk Joseph J
7 Feb 2025
Exec VP, CFO
Sold after exercise
13,015
$153.89
$2.00M
Decker Robert J
30 Aug 2024
VP Corporate Controller
Sold after exercise
5,635
$165.06
$930.11K
Taubert Jennifer L
9 Feb 2024
EVP, WW Chair, Pharmaceuticals
Sold after exercise
59,397
$156.27
$9.28M
Hait William
26 Jul 2023
See Remarks
Sold after exercise
14,698
$172.00
$2.53M
Wolk Joseph J
13 Dec 2022
Exec VP, CFO
Sold after exercise
12,926
$179.62
$2.32M
Wolk Joseph J
13 Dec 2022
Exec VP, CFO
Sold after exercise
1,855
$179.46
$332.91K
McEvoy Ashley
30 Nov 2022
EVP, WW Chair, MedTech
Sold after exercise
71,923
$175.46
$12.62M
McEvoy Ashley
30 Nov 2022
EVP, WW Chair, MedTech
Sold after exercise
1,400
$176.09
$246.53K
Taubert Jennifer L
22 Nov 2022
EVP, WW Chair, Pharmaceuticals
Sold after exercise
76,923
$176.78
$13.60M
Decker Robert J
18 Nov 2022
Controller, CAO
Sold after exercise
16,928
$175.00
$2.96M
Wengel Kathryn E
9 Nov 2022
EVP, Chief GSC Officer
Sold after exercise
16,410
$173.42
$2.85M
Mongon Thibaut
4 Nov 2022
Exec VP, WW Chair, Consumer
Sold after exercise
18,293
$171.22
$3.13M
Mongon Thibaut
4 Nov 2022
Exec VP, WW Chair, Consumer
Sold after exercise
16,953
$171.14
$2.90M
Hait William
24 Oct 2022
See Remarks
Sold after exercise
13,813
$171.55
$2.37M
Hait William
24 Oct 2022
See Remarks
Sold after exercise
1,187
$171.55
$203.63K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$170.76
$17.08K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
100
$171.36
$17.14K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
98
$171.36
$16.79K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
91
$170.76
$15.54K
Fasolo Peter
24 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
26
$171.36
$4.46K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Fasolo Peter
19 Oct 2022
Exec VP, Chief HR Officer
Sold after exercise
200
$164.50
$32.90K
Showing 250 of 434 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 563
Amendments (4/A) skipped 2
Filings about a different issuer 12
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 163
Sales at will 246
Transactions with no price 0
Shares from compensation/vesting 9,708,544
Sales filed before the plan box existed 235
History held since 9 Sep 2016